- Home
- BEAT vs MBOT Comparison
BEAT vs MBOT Comparison
Compare BEAT & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- MBOT
- Stock Information
- Founded
- BEAT 2015
- MBOT 2010
- Country
- BEAT United States
- MBOT United States
- Employees
- BEAT N/A
- MBOT N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- MBOT Medical/Dental Instruments
- Sector
- BEAT Technology
- MBOT Health Care
- Exchange
- BEAT Nasdaq
- MBOT Nasdaq
- Market Cap
- BEAT 65.1M
- MBOT 56.9M
- IPO Year
- BEAT 2021
- MBOT N/A
- Fundamental
- Price
- BEAT $2.08
- MBOT $1.59
- Analyst Decision
- BEAT Buy
- MBOT Strong Buy
- Analyst Count
- BEAT 1
- MBOT 1
- Target Price
- BEAT $8.00
- MBOT $9.00
- AVG Volume (30 Days)
- BEAT 131.3K
- MBOT 3.8M
- Earning Date
- BEAT 03-19-2025
- MBOT 03-26-2025
- Dividend Yield
- BEAT N/A
- MBOT N/A
- EPS Growth
- BEAT N/A
- MBOT N/A
- EPS
- BEAT N/A
- MBOT N/A
- Revenue
- BEAT N/A
- MBOT N/A
- Revenue This Year
- BEAT N/A
- MBOT N/A
- Revenue Next Year
- BEAT N/A
- MBOT N/A
- P/E Ratio
- BEAT N/A
- MBOT N/A
- Revenue Growth
- BEAT N/A
- MBOT N/A
- 52 Week Low
- BEAT $1.35
- MBOT $0.82
- 52 Week High
- BEAT $3.48
- MBOT $3.38
- Technical
- Relative Strength Index (RSI)
- BEAT 39.34
- MBOT 41.87
- Support Level
- BEAT $2.05
- MBOT $2.00
- Resistance Level
- BEAT $2.37
- MBOT $2.21
- Average True Range (ATR)
- BEAT 0.18
- MBOT 0.22
- MACD
- BEAT -0.02
- MBOT -0.08
- Stochastic Oscillator
- BEAT 21.24
- MBOT 0.00
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.